ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981

Reviewers Found For Chronobiolgy

June 30, 1989

IOM Selects Advisors To Defense Department

February 5, 1993

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

For A Better View Of Molecular Targets, NCI Project To Draw Pictures Of Cancers.

June 15, 2001